Empagliflozin has kidney protective effects and reduces heart failure outcomes across baseline kidney function among patients with acute myocardial infarction (MI), according to a study published ...

Drug combination shows promise for early treatment after myocardial infarction by Germans Trias i Pujol Research Institute ...

Acute myocardial infarction complicated by cardiogenic shock (AMICS) is a critical syndrome with a high risk of morbidity and mortality. Current management consists of coronary revascularisation, ...

Sotagliflozin, a dual SGLT1/2 inhibitor, shows benefit specifically for reducing myocardial infarction and stroke risks. Among patients with type 2 diabetes and chronic kidney disease (CKD) at ...

Each year approximately 750,000 people in the United States experience ST-segment elevation myocardial infarction (STEMI) and up to 10% die within 30 days.

No. 6 seed Penn State used two first-half interception returns for touchdowns to jumpstart a 38-10 blowout of No. 11 seed SMU in the first round of the College Football Playoff on Saturday at ...

Learn about the difference between myocardial ischemia and myocardial infarction. This article looks at causes, symptoms, treatments, and more.

Article citations More>> Nikolaos, N.F. (2015) Pathophysiology of Myocardial Infarction. Albert Einstein College of Medicine. has been cited by the following article: TITLE: Myocardial Infarction and ...

ABSTRACT: Myocardial infarction is the most common form of cardiovascular disease worldwide, claiming over 9 million lives per year. As such, understanding the pathophysiology, epidemiology, signs, ...

BACKGROUND: Thromboembolic events, including myocardial infarction (MI) or stroke, caused by the rupture or erosion of unstable atherosclerotic plaques are the leading cause of death worldwide.

Most trials that have shown a benefit of beta-blocker treatment after myocardial infarction included patients with large myocardial infarctions and were conducted in an era before modern biomarker- ...